Anti-Rheumatics Market 2023-2028 | Trends, Growth, Share and Forecast

According to the latest report by IMARC Group, titled, “Anti-Rheumatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global anti-rheumatics market size reached US$ 62.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 73.9 Billion by 2028, exhibiting a growth rate (CAGR) of 2.7% during 2023-2028.

Rheumatic refers to an autoimmune inflammatory disease that affects the joints, tendons, ligaments, bones, and muscles. Its symptoms include aching, stiffness, tenderness, and swelling in joints, weight loss, fever, fatigue, and weakness. Its treatment is achieved using different drugs known as anti-rheumatics. Anti-rheumatics includes disease-modifying anti-rheumatics drugs (DMARD’s), nonsteroidal anti-inflammatory drugs (NSAID’s), Corticosteroids, and uric acid drugs, which prevent joint damage, decrease inflammation, and aid in slowing down the progression of the disease.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anti-rheumatics-market/requestsample

Anti-Rheumatics Market Trends and Drivers:

At present, the growing geriatric population and rising cases of rheumatoid arthritis represent one of the key factors positively influencing the market across the globe. In addition, unhealthy dietary patterns, sedentary lifestyles and consequently increasing obesity are worsening the symptoms of rheumatoid arthritis. In line with this, the increasing prevalence of diabetes among individuals are contributing to the market growth. Moreover, the growing awareness about the treatment available for anti-rheumatics is fueling the market. Additionally, increasing investments in research and development (R&D) activities for introducing new drugs and increasing focus on lowering drug prices are stimulating the growth of the market. Other factors, such as rising disposable incomes, increasing affordability of rheumatoid arthritis treatment, and the easy availability of prescription-based and over-the-counter drugs, are creating a favorable market outlook.

Anti-Rheumatics Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• AbbVie Inc. (ABBV)
• Amgen Inc.
• AstraZeneca plc
• Biogen Inc.
• Bristol-Myers Squibb Company
• Celltrion Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Johnson & Johnsons
• Pfizer Inc.
• Sanofi SA.

The report has segmented the market on the basis of Type, Drug Class, Route of Drug Administration, Distribution Channel and Region.

Breakup by Type:

• Prescription-based Drugs
• Over-the-Counter Drugs

Breakup by Drug Class:

• Disease Modifying Anti-Rheumatics Drugs (DMARD’s)
• Nonsteroidal Anti-Inflammatory Drugs (NSAID’s)
• Corticosteroids
• Uric Acid Drugs
• Others

Breakup by Route of Drug Administration:

• Oral
• Parenteral
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/anti-rheumatics-market

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group